Sanofi EBITDA 2012-2026 | SNY

Sanofi EBITDA for the quarter ending March 31, 2026 was $2.441B, a 0.07% decline year-over-year.

  • Sanofi 2024 EBITDA was 12.1B, a 18.13% decline from 2023.
  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Sanofi EBITDA 2012-2026 | SNY

  • Sanofi 2024 EBITDA was 12.1B, a 18.13% decline from 2023.
  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B